LifeMD vs Noom

Neither LifeMD nor Noom has an FDA warning letter on record. On brand-name tirzepatide pen, Noom costs $1,188 less a year at standing rates: $349 a month against $448 a month at LifeMD.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

LifeMD / Noom

LifeMD logo

LifeMD

6.0/10

Noom logo

Noom

5.8/10

FDA warning letters
None on record
None on record
Pharmacy
Brand-name only; no compounding
None named in our record
Lowest standing price
$298/moBrand-name semaglutide pill
$179/moCompounded semaglutide injection
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither LifeMD nor Noom pays us. Links to them earn nothing. Scores: LifeMD 6.0, Noom 5.8. How we are paid

What the record shows

  1. 01

    Neither LifeMD nor Noom has an FDA warning letter on record.

  2. 02

    Noom names no compounding pharmacy in our record. LifeMD sells brand-name medication only.

  3. 03

    On brand-name tirzepatide pen, Noom costs $1,188 less a year at standing rates: $349 a month against $448 a month at LifeMD.

  4. 04

    Only LifeMD lists a price for brand-name semaglutide pen and brand-name semaglutide pill. Only Noom lists a price for compounded semaglutide injection.

  5. 05

    LifeMD lists all 50 states. Noom publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

LifeMD

Noom

Brand-name tirzepatide pen

$448/mo

$5,376 a year

$349/moLower

$4,188 a year

Compounded semaglutide injection
Not sold or not priced

$179/mo

$2,148 a year

Brand-name semaglutide pen

$348/mo

$4,176 a year

Not sold or not priced
Brand-name semaglutide pill

$298/mo

$3,576 a year

Not sold or not priced
Price includes
Clinician visits, labs, coaching
Clinician visits, coaching
Billed separately
Medication
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
Not stated
Refunds
Money-back guarantee after 12 months if under 10% loss and all conditions met
Refunds only before a prescription is written; renewal charges are not refunded

Read off each seller’s own pages. LifeMD: October 31, 2026. Noom: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for LifeMD

6.0/10
  • Sells brand-name semaglutide pen and brand-name semaglutide pill, which Noom does not price
  • Price leaves out medication

The case for Noom

5.8/10
  • $1,188 a year less on brand-name tirzepatide pen
  • Sells compounded semaglutide injection, which LifeMD does not price
  • Names no compounding pharmacy
  • Publishes no state list

Scores

LifeMD 6.0 · Noom 5.8 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
0.9

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.0A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.5A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

LifeMD vs Noom: questions

Neither LifeMD nor Noom has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Noom names no compounding pharmacy in our record. LifeMD sells brand-name medication only.
Noom, by $1,188 a year at standing rates. LifeMD: $448 a month, about $5,376 a year. Noom: $349 a month, about $4,188 a year.
LifeMD states you can cancel at any time; refunds: money-back guarantee after 12 months if under 10% loss and all conditions met. Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded.
Neither LifeMD nor Noom pays us. Links to them earn nothing. Scores: LifeMD 6.0, Noom 5.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks